Lysozyme

DB13260InvestigationalProtein Based Therapies

Lysozyme is an enzyme indicated in the treatment of gastrointestinal disorders in infants, as well as Herpes zoster and Herpes simplex. A medication used to treat digestive problems in infants, as well as Shingles and Herpes.

Mechanism: Pharmacologically active on Peptidoglycan precursors
Curator reviewed
Code names: E-1105 · INS-1105 · INS NO.1105

Resolves to

Compound

UNII968JKA7T33CAS12650-88-3

Clinical / RWD

RxNorm7094ATCD06BB07ATCJ05AX02

What you can answer from here — as of July 17, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

8Structured indicationsCondition, population, route and combination as fields, not prose

1ContraindicationEach with its own population and attribute set

35Marketed productsAcross 5 countries and 13 labellers

2ATC codesIncluding every combination product, plus 9 drug categories

6+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Lysozyme, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account